GLP-2 TZ
Metabolic Research Peptide
Size: 10mg
GLP-2 TZ is a dual GIP and GLP-1 receptor agonist, studied for glucose metabolism, appetite regulation, and metabolic signaling in research models.
GLP-2 TZ
Dual receptor peptide that engages both GLP-1 and GIP pathways
Studied for metabolic and glucose-regulation research
Investigated for effects on appetite signaling and energy balance
Long-acting profile in research models
Commonly referenced in once-weekly research protocols
Research Use Notes
Supplied as lyophilized powder
Requires reconstitution before use
Research Water required for mixing (sold separately)
Swirl gently, never shake
Storage
Store sealed lyophilized vial frozen for long-term holding
Keep at 2 to 8°C once in active use
Protect from light and ambient heat
Handling
Maintain sterile technique throughout reconstitution
For laboratory research use only
Avoid repeated freeze-thaw cycles to preserve integrity
Certificate of Analysis
Independently 8x Tested by Kovera Labs and/or ILS Labs
(Click here to learn about 8x testing)
All certificates are issued by independent ISO-accredited laboratories. Lot-specific documents are made available to qualified research professionals on request.
Frequently Bought Together
Commonly paired to support consistent, reliable experimentation.
Cagrilintide
$80.00Metabolic Research Peptide
BPC-157
$60.00Tissue Repair Peptide
Compound Information
Technical specifications
What Is GLP-2 TZ?
LY3298176 · GIP / GLP-1 dual agonist
- Type
- Synthetic peptide
- CAS Number
- 2023788-19-2
- Molecular Weight
- 4,813 g/mol
- Amino Acids
- 39
- Fatty Acid Chain
- C20 diacid
Stability Information
-20°C
24+ months
2-8°C
~30 days
Sources & References
Peer-reviewed research
GLP-2 TZ Once Weekly for the Treatment of Obesity (SURMOUNT-1)
2022 · DOI: 10.1056/NEJMoa2206038 · Jastreboff AM, et al.
View SourceNew England Journal of MedicineGLP-2 TZ versus Semaglutide Once Weekly in Type 2 Diabetes (SURPASS-2)
2021 · DOI: 10.1056/NEJMoa2107519 · Frías JP, et al.
View SourceThe LancetGLP-2 TZ Monotherapy in Type 2 Diabetes (SURPASS-1)
2021 · DOI: 10.1016/S0140-6736(21)01324-6 · Rosenstock J, et al.
View SourcePubMed CentralGLP-2 TZ Cardiometabolic Effects — Systematic Review
Review · 2023
View SourcePubChemGLP-2 TZ Compound Information
View SourceClinicalTrials.govGLP-2 TZ Clinical Trials Registry
View SourceProducts are intended solely for laboratory and scientific research purposes. Not intended for human consumption, veterinary use, diagnosis, treatment, cure, or prevention of disease.
All the research compounds you need, with the confidence that every batch is 8× tested before it ships.
Subscribe to our Newsletter
Subscribe to our newsletter to get daily insights, news, updates.